Compound information
- Natural Products
- ZC545367
- Molecular Formula
- C18H27N3O4S
- Molecular Weight
- 381.172227344 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-[4-(benzenesulfonyl)piperazin-1-yl]piperidine-1-carboxylate
- InChI
- InChI=1S/C18H27N3O4S/c1-2-25-18(22)20-10-8-16(9-11-20)19-12-14-21(15-13-19)26(23,24)17-6-4-3-5-7-17/h3-7,16H,2,8-15H2,1H3
- InChI Key
- QOQNPUBQRWWMCW-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCC(N2CCN(S(=O)(=O)c3ccccc3)CC2)CC1
- Source
- ZINC000035624748
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 70.16 Å2 | LogP | 1.888 |
LogS | -2.88 | LogD | 1.9 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.017 | Pgp substrate | 0.138 |
HIA | 0.968 | F20 % | 0.97 |
F30 % | 0.631 | Caco-2 | -4.382 |
MDCK | -4.762 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.6 | PPB | 79.051 |
VD | 1.247 | Fu | 0.358 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.01 | CYP1A2 substrate | 0.429 |
CYP2A6 substrate | 0.502 | CYP2B6 substrate | 0.737 |
CYP2C19 inhibitor | 0.42 | CYP2C19 substrate | 0.747 |
CYP2C8 substrate | 0.575 | CYP2C9 inhibitor | 0.074 |
CYP2C9 substrate | 0.976 | CYP2D6 inhibitor | 0.073 |
CYP2D6 substrate | 0.718 | CYP2E1 substrate | 0.175 |
CYP3A4 inhibitor | 0.028 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.295 | CL | 4.71 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.489 | Hepatotoxicity | 0.597 |
Mutagenicity | 0.527 | Rat Oral Acute Toxicity | 0.193 |
FDAMDD | 0.491 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.289 | Eye Corrosion | 0.003 |
Eye Irritation | 0.032 | Respiratory Toxicity | 0.757 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.248 | IGC50 | 2.474 |
LC50FM | -1.106 | LC50DM | -0.943 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.464 | NR-AR-LBD | 0.382 |
NR-AhR | 0.026 | NR-Aromatase | 0.011 |
NR-ER | 0.17 | NR-ER-LBD | 0.314 |
NR-PPAR-gamma | 0.067 | SR-ARE | 0.102 |
SR-ATAD5 | 0.274 | SR-HSE | 0.141 |
SR-MMP | 0.012 | SR-p53 | 0.077 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.